Immunoclin (Immunoclin) Total Liabilities : $2.84 Mil (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Total Liabilities?

Immunoclin's Total Liabilities for the quarter that ended in Oct. 2014 was $2.84 Mil.

Immunoclin's quarterly Total Liabilities increased from Apr. 2014 ($1.15 Mil) to Jul. 2014 ($1.78 Mil) and increased from Jul. 2014 ($1.78 Mil) to Oct. 2014 ($2.84 Mil).

Immunoclin's annual Total Liabilities increased from Feb. 2012 ($0.09 Mil) to Jan. 2013 ($0.51 Mil) and increased from Jan. 2013 ($0.51 Mil) to Jan. 2014 ($0.73 Mil).

Immunoclin Total Liabilities Historical Data

The historical data trend for Immunoclin's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Total Liabilities Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Total Liabilities

0.09

0.51

0.73

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Total Liabilities	Get a 7-Day Free Trial									0.08	0.09	1.15	1.78	2.84

Immunoclin Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Immunoclin's Total Liabilities for the fiscal year that ended in Jan. 2014 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.725	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.73

Total Liabilities	=	Total Assets (A: Jan. 2014 )	-	Total Equity (A: Jan. 2014 )
	=	21.039	-	20.314
	=	0.73

Immunoclin's Total Liabilities for the quarter that ended in Oct. 2014 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.84	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.84

Total Liabilities	=	Total Assets (Q: Oct. 2014 )	-	Total Equity (Q: Oct. 2014 )
	=	20.391	-	17.55
	=	2.84

Immunoclin Total Liabilities Related Terms

Thank you for viewing the detailed overview of Immunoclin's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines